LABORATORIO FARMAC.ERFO (RK7) — Free Cash Flow Generation Index
LABORATORIO FARMAC.ERFO (RK7) has a Free Cash Flow Generation Index of -0.11x as of December 2023. Free cash flow of €-148.29K represents 0% of operating cash flow (€1.30 Million). See how liquid is LABORATORIO FARMAC.ERFO's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
LABORATORIO FARMAC.ERFO Free Cash Flow Generation Index (2021–2023)
Historical FCF Generation Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. Explore RK7 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year Free Cash Flow Generation Index for LABORATORIO FARMAC.ERFO. For the full company profile including market capitalisation, see RK7 market cap.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.11x | €-148.29K | €1.30 Million | €1.45 Million | ▲ +79.1% |
| 2022 | -0.55x | €-416.06K | €761.80K | €1.18 Million | ▼ -161.1% |
| 2021 | 0.89x | €2.03 Million | €2.27 Million | €242.84K | — |